But you are right about the major role of “extraneous” environmental factors, and this is why we started our studies with a systematic perturbation of diet—low fat versus very high fat (citations are above). The correlation of longevity on these profoundly different diets is about r = 0.6 based on an analysis of 76 balanced cohorts of strains on the two diets—about 10 females per strain per diet. With the deep replication (10 identical twins per treatment) these are rock solid data. A correlation of 0.6 gives “explained variance” of only 36% (r^2), so that highlights the major effect of diet on longevity. And the gene variants that modulate longevity on the two diets are, as expected, very different.
Bottom line: the genetics of longevity is the genetics of gene-by-environment interaction—your major point.
You can see the same with testosterone. Men with higher testosterone live longer but giving people testosterone doesn't increase lifespan.
Aspirin reduce inflammatory response, which testosterone also do. The more likely reason why Aspirin helps to improve lifespans in men is that it steps in when testosterone has fallen through aging, stepping in to do the role of testosterone. High inflammatory response can be quite deadly, especially in connection with cardiovascular problems (a common cause of death for men).
17αEstradiol is a weaker form of estrogen. Men that has either too high or too low amount of estrogen has an significant increase in heart failure. When testosterone goes down during old age, estrogen tend to also go down as estrogen is produced in men through converting testosterone. Again it seems that the drug can help by stepping in after a fall in testosterone.
NDGA (nordihydroguaiaretic acid) is an xenohormone that imitates estrogen. See above about estrogen.
Protandim is a mix of five herbs, including green tea. Can't tell anything about that, and FDA has issued a warning against the manufacturer for false claims.
As of Cohort 10, C2014, 7 compounds have shown significant extension of median lifespan:
Aspirin – Increased lifespan in males but not females (Strong et al., 2008).
Rapamycin – Increased mean and maximal lifespan in both males and females when initiated at 20 months of age (Harrison et al., 2009) and when initiated at 9 months of age (Miller et al., 2011). Females responded more robustly than males at equivalent doses; when ~ equal blood levels were achieved, response was also about equivalent in females and males (Miller et al., 2013).
17αEstradiol – Increased lifespan in males but not females, at 4.8 ppm dose (Harrison et al., 2013) and 14.4 ppm dose (Strong et al., 2016).
Acarbose – Increased lifespan in both males and females, but the effects were greater in males, when initiated at 4 months of age (Harrison et al., 2013), but only males responded when initiated at 16 months of age (Strong et al., 2016).
NDGA (nordihydroguaiaretic acid) – Increased mean lifespan in males but not females (Strong et al., 2008), even at doses that gave equivalent blood levels in males and females (Harrison et al., 2013).
Protandim® – Increased lifespan in males but not females (Strong et al., 2016).
Glycine – Started at 9 months. Increased lifespan in males and females (Miller et al., 2019).
Canagliflozin